Adlai Nortye Ltd (ANL) - Narx-foyda koeffitsiyenti

Adlai Nortye (ANL) korporativ emblemasi va logotipi

Adlai Nortye Ltd. (ANL) narxining evolyutsiyasi -26.10 qiymatidagi dinamikani namoyish etmoqda, shu bilan birga kompaniya buparlisib testlarining yakunlanishini kutmoqda va FDA uchun hujjatlarni tayyorlamoqda. Joriy holat daromadli mahsulotlarning yo'qligi va salbiy pul oqimi tufayli naqd zaxiralarga tayanadi. Kelajakda Adlai Nortye Ltd. (ANL) qattiq o'smalar uchun innovatsion davolash usullarini tijoriyashtirish orqali daromad olishni rejalashtirmoqda.

adlainortye.com (ANL): Narxning foydaga nisbati 13.04.2026dan 17.11.2026gacha

Adlai Nortye Limited (ANL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning jamlanma tahlili:Adlai Nortye Ltd ANL
Adlai Nortye Ltd original mahsuloti

Adlai Nortye Ltd. (ANL) uchun joriy P/E koeffitsiyenti biznesning bozor qiymati va uning sof foydasi o'rtasidagi bog'liqlikni aks ettiradi, bu esa investorlarga foydaning har bir birligi uchun xarajatlarni baholash imkonini beradi. Manfiy FCF va qimmatga tushadigan tadqiqotlar bilan tavsiflanadigan biotexnologiya sektorida ushbu metrika FDA tasdig'idan keyingi mahsulotlar liniyasining kutilayotgan tijorat muvaffaqiyatining sezgir ko'rsatkichi bo'lib xizmat qiladi, aynan shu nuqtada spekulyativ xavf haqiqiy daromadga aylanadi.

Raqobatdosh kompaniyalar tahlili

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|RVMD (RevMed) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (ascentage.com)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis Corp (PSNL) - Narxning foydaga nisbati|Erasca Corp - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath Systems Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Therapeutics, Inc. YMAB|P/E multiplikatori AURA|Narx-foyda koeffitsiyenti Candel Therapeutics, Inc. CADL|P/E multiplikatori ARAY (Accuray, Inc.)|SELLAS Life Sciences - Narxning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology, Inc. - Bozor narxining sof foydaga nisbati|HURA (TuHURA Biosciences) - Narx-foyda koeffitsiyenti|TARA: Bozor narxining sof foydaga nisbati|Narx-foyda koeffitsiyenti FATE|WHWK: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TCRX (TScan Therapeutics Inc)|Biznesning o‘zini qoplash muddati Champions Oncology Inc|P/E multiplikatori XBIT (XBiotech Inc.)|Kompaniya qiymatining sof foydaga nisbati CVM|OS Therapies Inc. - P/E multiplikatori|RADX - P/E multiplikatori|ARTV: P/E multiplikatori|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV